Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Exodus and MetaMask Partner to Bring XO Swap’s Bridge Functionality to Millions of Wallet Users
-
MiniLuxe Announces Planned Share Issuance for a New Studio Location Acquisition in the DFW (Dallas Fort Worth) Region
-
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
-
Lithium Argentina Reports Second Quarter 2025 Results
-
Kinross Files Early Warning Report with respect to Asante Gold
-
Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week
-
Plum Role Model™ Named a 2025 Top HR Product of the Year by HR Executive
-
American Tungsten Provides Update on Site Rehabilitation Progress and Federal Engagement
-
Papa Johns Canada Brings Hawaii Home with The Aloha Trio
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
BioCryst Announces Departure of Dr. Helen Thackray
-
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
-
Rocky Shore Gold Announces Non-Brokered Private Placement
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
WeightWatchers Announces Second Quarter 2025 Results
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
-
Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds
-
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update
-
FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response
-
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
-
I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
-
Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update
-
And the Winners Are: HR Executive and HR Tech Announce 2025 Top HR Products of the Year
-
FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156
-
BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference
-
Sionna Therapeutics Reports Second Quarter 2025 Financial Results
-
FitLife Brands Closes Acquisition of Irwin Naturals
-
Village Farms International Delivers Record Profitability and Performance from Continuing Operations in Q2/25
-
Intermex Reports Second-Quarter Results
-
Harvard Bioscience Announces Second Quarter 2025 Financial Results
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025
-
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
-
Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update
-
CW Petroleum Corp (OTCQB: CWPE) Reduces Authorized Shares of Common Stock
-
GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2
-
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome
-
CECO Environmental Announces Upcoming Investor Conferences
-
Interpublic Partners with Aaru to Leverage AI-Powered Predictive Simulations to Accelerate, Scale and Optimize Marketing
-
OTC Markets Group Welcomes Limitless X Holdings Inc. to OTCQX
-
Signify share repurchase period update
-
FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response
-
Serstech Receives 1.7 MSEK Order from Vietnam
-
MAG Silver Reports Second Quarter Financial Results
-
Bitcoin Swift Announces Stage 4 Presale Progress With 106% APY and $580K Raised
-
VDIAGTOOL Celebrates 8th Anniversary with Launch of the VD80BT Lite: Pro-Level Diagnostics at an Affordable Price
-
LYNO AI Hits Key Milestone in Early Presale with 176K Tokens Sold at Launch Price
-
Vantage Drilling International Ltd. Announces Completion of the Sale of the Tungsten Explorer
-
MAG Announces Third Dividend
-
Cogni AI Introduces Autonomous Agents for Web3 Integration

